Article
A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms.
Current oncology (Toronto, Ont.) - 23 Apr 2024
Abdulbaki Rami, Pullarkat Sheeja T
Abstract excerpt
Myelodysplastic neoplasm (MDS) is a heterogeneous group of clonal hematological disorders that originate from the hematopoietic and progenitor cells and present with cytopenias and morphologic dysplasia with a propensity to progress to bone marrow failure or acute myeloid leukemia (AML). Genetic evolution plays a critical role in the pathogenesis, progression, and clinical outcomes of MDS. This process involves...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
